We are live on ! Find out more
PPBT

Purple Biotech
PPBT

5 hedge funds and large institutions have $43K invested in Purple Biotech in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

51% less capital invested

Capital invested by funds: $87K → $43K (-$44K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$10K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$25.1K
2
SM
Sabby Management
Florida
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$20K -$25.1K -15 -52%
KWM
2
Kingsview Wealth Management
Oregon
$12K – – –
VF
3
Virtu Financial
New York
$9K +$10K +6 New
ASN
4
Advisory Services Network
Georgia
$1K – – –
UBS Group
5
UBS Group
Switzerland
$1K – – –
SM
6
Sabby Management
Florida
– -$14K -7 Closed

PPBT Hedge Fund Activity: Q3 2019 in Review

5 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2019, worth a combined $43K — down 51% from $87K a quarter earlier.

Fund positioning in PPBT was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $10K. The largest seller was Morgan Stanley, cutting an estimated $25.1K.

  • 5 institutional investors held Purple Biotech (PPBT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $43K of Purple Biotech stock for Q3 2019, down 51% quarter-over-quarter.
  • 1 fund opened new Purple Biotech positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Purple Biotech buyer in Q3 2019 was Virtu Financial, an estimated $10K added.
  • The largest Purple Biotech seller in Q3 2019 was Morgan Stanley, an estimated $25.1K sold.

Based on aggregated 13F filings for Q3 2019.